These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30598263)

  • 61. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
    He C; Wu T; Hao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3093-3099. PubMed ID: 30146257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
    Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
    Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatocellular carcinoma and chemotherapy: the role of p53.
    Brito AF; Abrantes AM; Pinto-Costa C; Gomes AR; Mamede AC; Casalta-Lopes J; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF
    Chemotherapy; 2012; 58(5):381-6. PubMed ID: 23257706
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
    J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Xanthatin induces apoptosis by activating endoplasmic reticulum stress in hepatoma cells.
    Shi TL; Zhang L; Cheng QY; Yu JS; Liu J; Shen YJ; Feng XJ; Shen YX
    Eur J Pharmacol; 2019 Jan; 843():1-11. PubMed ID: 30389633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
    Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
    Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GADD45β induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia.
    Ma D; Shen B; Seewoo V; Tong H; Yang W; Cheng X; Jin Z; Peng C; Qiu W
    Oncotarget; 2016 Jun; 7(24):37215-37225. PubMed ID: 27177086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
    Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein.
    Sieben M; Herzer K; Zeidler M; Heinrichs V; Leuchs B; Schuler M; Cornelis JJ; Galle PR; Rommelaere J; Moehler M
    World J Gastroenterol; 2008 Jun; 14(24):3819-28. PubMed ID: 18609705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
    Ortega JF; de Conti A; Tryndyak V; Furtado KS; Heidor R; Horst MA; Fernandes LH; Tavares PE; Pogribna M; Shpyleva S; Beland FA; Pogribny IP; Moreno FS
    Oncotarget; 2016 Apr; 7(17):24339-47. PubMed ID: 27013579
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nimesulide inhibits the proliferation of HepG2 by up-regulation of Smad4.
    Yang S; Guo R; Huang L; Yang L; Jiang D
    Indian J Pharmacol; 2012; 44(5):599-601. PubMed ID: 23112421
    [TBL] [Abstract][Full Text] [Related]  

  • 77. AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways.
    Yin W; Zhang K; Deng Q; Yu Q; Mao Y; Zhao R; Ma S
    Bioengineered; 2021 Dec; 12(1):8679-8689. PubMed ID: 34635007
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TIAF1 self-aggregation in peritumor capsule formation, spontaneous activation of SMAD-responsive promoter in p53-deficient environment, and cell death.
    Chang JY; Chiang MF; Lin SR; Lee MH; He H; Chou PY; Chen SJ; Chen YA; Yang LY; Lai FJ; Hsieh CC; Hsieh TH; Sheu HM; Sze CI; Chang NS
    Cell Death Dis; 2012 Apr; 3(4):e302. PubMed ID: 22534828
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
    Lu WJ; Lee NP; Kaul SC; Lan F; Poon RT; Wadhwa R; Luk JM
    Cell Death Differ; 2011 Jun; 18(6):1046-56. PubMed ID: 21233847
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of p53 stability and apoptosis by a ROR agonist.
    Wang Y; Solt LA; Kojetin DJ; Burris TP
    PLoS One; 2012; 7(4):e34921. PubMed ID: 22509368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.